Status:

RECRUITING

A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis

Lead Sponsor:

Qianfoshan Hospital

Conditions:

Interstitial Lung Disease

Eligibility:

All Genders

18-80 years

Brief Summary

The goal of this observational study is to learn about risk of progressive pulmonary fibrosis (PPF). The main questions it aims to answer are: * Risk factors of PPF * Prevalence of PPF * Mortality of...

Eligibility Criteria

Inclusion Criteria:

  • 18-80 years old
  • Agree and sign the informed consent form
  • Interstitial lung disease patients with imaging features of pulmonary fibrosis

Exclusion Criteria:

  • Patients with idiopathic pulmonary fibrosis (IPF)
  • Pregnant or lactating women
  • mental illness or cognitive impairment
  • participating in other clinical studies
  • Unable to sign informed consent form

Key Trial Info

Start Date :

July 27 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

610 Patients enrolled

Trial Details

Trial ID

NCT05895409

Start Date

July 27 2023

End Date

June 1 2028

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, China, 250000

A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis | DecenTrialz